Virtus Duff & Phelps Real Asset I (VADIX)
Nasdaq • Currently unchanged in today's trading session
1 member of Congress has disclosed 2 trades in Virtus Duff & Phelps Real Asset I (VADIX) via STOCK Act filings. The most recent disclosure was a sale by Chris Coons on 27 June 2022. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
Virtus Duff & Phelps Real Asset I is currently trading at $17.41, positioned at 74% of its 52-week range ($15.55 – $18.08).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Virtus Duff & Phelps Real Asset I Price History and Technical Analysis
Congressional Trading Activity for VADIX
| Chris Coons | 27 Jun 2022 | 14 Aug 2023 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Chris Coons | 23 Dec 2020 | 15 Jul 2021 | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Frequently Asked Questions about VADIX
- Which members of Congress have traded VADIX?
- 1 member of Congress has disclosed 2 trade in Virtus Duff & Phelps Real Asset I (VADIX) under the STOCK Act: Chris Coons.
- When was VADIX most recently disclosed by Congress?
- The most recent VADIX disclosure was a sale by Chris Coons on 27 June 2022.
- What is the total disclosed congressional trading volume for VADIX?
- Members of Congress have disclosed approximately $8K in VADIX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in VADIX?
- This VADIX page updates as soon as new STOCK Act disclosures are filed for Virtus Duff & Phelps Real Asset I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track VADIX in Congress
See when politicians buy or sell this stock